333 related articles for article (PubMed ID: 33347711)
1. Targeted nanomedicines for the treatment of bone disease and regeneration.
Ordikhani F; Zandi N; Mazaheri M; Luther GA; Ghovvati M; Akbarzadeh A; Annabi N
Med Res Rev; 2021 May; 41(3):1221-1254. PubMed ID: 33347711
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnology for Targeted Drug Delivery to Treat Osteoporosis.
Kaur M; Nagpal M; Aggarwal G
Curr Drug Targets; 2023; 24(1):2-12. PubMed ID: 36200208
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. Evaluating Nanomedicines: Obstacles and Advancements.
Swierczewska M; Crist RM; McNeil SE
Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
[TBL] [Abstract][Full Text] [Related]
5. Ligand-based active targeting strategies for cancer theranostics.
Bandyopadhyay A; Das T; Nandy S; Sahib S; Preetam S; Gopalakrishnan AV; Dey A
Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3417-3441. PubMed ID: 37466702
[TBL] [Abstract][Full Text] [Related]
6. The Advancement and Obstacles in Improving the Stability of Nanocarriers for Precision Drug Delivery in the Field of Nanomedicine.
Mahajan K; Bhattacharya S
Curr Top Med Chem; 2024; 24(8):686-721. PubMed ID: 38409730
[TBL] [Abstract][Full Text] [Related]
7. Targeting Drug Delivery in the Elderly: Are Nanoparticles an Option for Treating Osteoporosis?
Thurner GC; Haybaeck J; Debbage P
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445639
[TBL] [Abstract][Full Text] [Related]
8. The advances in nanomedicine for bone and cartilage repair.
Qiao K; Xu L; Tang J; Wang Q; Lim KS; Hooper G; Woodfield TBF; Liu G; Tian K; Zhang W; Cui X
J Nanobiotechnology; 2022 Mar; 20(1):141. PubMed ID: 35303876
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of nanomedicines for promoting vascular regeneration in ischemic diseases.
Zhuang J; Zhang X; Liu Q; Zhu M; Huang X
Theranostics; 2022; 12(14):6223-6241. PubMed ID: 36168632
[TBL] [Abstract][Full Text] [Related]
10. Insights into Active Targeting of Nanoparticles in Drug Delivery: Advances in Clinical Studies and Design Considerations for Cancer Nanomedicine.
Pearce AK; O'Reilly RK
Bioconjug Chem; 2019 Sep; 30(9):2300-2311. PubMed ID: 31441642
[TBL] [Abstract][Full Text] [Related]
11. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
Khaitan D; Reddy PL; Ningaraj N
Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of nanomedicines for prostate cancer: An update.
Lakshmanan VK
Investig Clin Urol; 2016 Jan; 57(1):21-9. PubMed ID: 26966723
[TBL] [Abstract][Full Text] [Related]
13. Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand.
Elzoghby AO; Abdelmoneem MA; Hassanin IA; Abd Elwakil MM; Elnaggar MA; Mokhtar S; Fang JY; Elkhodairy KA
Biomaterials; 2020 Dec; 263():120355. PubMed ID: 32932142
[TBL] [Abstract][Full Text] [Related]
14. Nanotechnology Inspired Advanced Engineering Fundamentals for Optimizing Drug Delivery.
Kassem AA
Curr Drug Targets; 2018; 19(15):1839-1854. PubMed ID: 29412103
[TBL] [Abstract][Full Text] [Related]
15. Bone-Targeted Nanoparticle Drug Delivery System: An Emerging Strategy for Bone-Related Disease.
Chen Y; Wu X; Li J; Jiang Y; Xu K; Su J
Front Pharmacol; 2022; 13():909408. PubMed ID: 35712701
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicines functionalized with anti-EGFR ligands for active targeting in cancer therapy: Biological strategy, design and quality control.
Nguyen PV; Allard-Vannier E; Chourpa I; Hervé-Aubert K
Int J Pharm; 2021 Aug; 605():120795. PubMed ID: 34119579
[TBL] [Abstract][Full Text] [Related]
17. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
19. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
20. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.
Muthu MS; Singh S
Nanomedicine (Lond); 2009 Jan; 4(1):105-18. PubMed ID: 19093899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
